Patients in a waiting area at a doctor's office

As a global biopharmaceutical company, our activities touch many people’s lives

Key facts

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.

AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Learn more

AZ Health Connections

  • US FDA Approves MOVANTIK™ (naloxegol) Tablets C-II 17 September 2014 01:22 BST

    On September 16, the US Food and Drug Administration approved MOVANTIK™ (naloxegol) tablets C-II as the first once-daily oral peripherally acting mu-opioid receptor antagonist (PAMORA) for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain. Opioids play an important role in chronic pain relief by binding to mu-receptors...